You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Islet Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • (no location specified)
Aug 4, 2023

Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • Unresectable Pancreatic Neuroendocrine Carcinoma
  • Lutetium Lu 177 Dotatate
  • +4 more
  • (no location specified)
Feb 10, 2022

Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Carcinoma Trial in United States

Completed
Has Results
  • Pancreatic Alpha Cell Carcinoma
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 14, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Stanford, California
    Stanford University Medical Center
Apr 8, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in Boston (everolimus, )

Terminated
Has Results
  • Gastrinoma
  • +6 more
  • Boston, Massachusetts
    Ecog-Acrin
Dec 1, 2020

Nephrologic Prognosis 10 Years After Diabetes Cell Therapy

Completed
  • Islet Transplantation
  • islet transplanted
  • non islet transplanted
  • Lille, France
    Lille University Hospital
Apr 28, 2022

Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived

Not yet recruiting
  • Islet Transplantation
  • Infusion of recipient T regulatory cell
  • Infusion of concomitant Donor Derived Vertebral Bone Marrow
  • Palo Alto, California
    Stanford University
Jul 25, 2023

Assessment of What Patients and Healthcare Providers Value

Unknown status
  • Gastric Adenocarcinoma
  • +2 more
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2020

Type 1 Diabetes Trial in Duarte (Allogenic Human Islet Cells, Immunosuppressive Agents, Gastrin 17)

Recruiting
  • Type 1 Diabetes Mellitus
  • Allogenic Human Islet Cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Islet Autotransplantation in Pancreatic Surgery

Recruiting
  • Diabetes
    • Milan, Italy
      Ospedale San Raffaele (OSR)
    Dec 1, 2022

    Diabetes type1 Trial (cePolytreg)

    Not yet recruiting
    • Diabetes type1
    • cePolytreg
    • (no location specified)
    Jul 8, 2022

    Type 1 Diabetes Trial in Edmonton (Islet isolation using BMX-010)

    Completed
    • Type 1 Diabetes
    • Islet isolation using BMX-010
    • Edmonton, Alberta, Canada
      University of Alberta
    May 5, 2022

    Benign Pancreatic Tumor, Chronic Pancreatitis, Recurrent Acute Pancreatitis Trial in Portland (Pancreatectomy, Quality-of-Life

    Not yet recruiting
    • Benign Pancreatic Neoplasm
    • +2 more
    • Pancreatectomy
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 7, 2022

    Diabetes, Type I Trial in Miami (islets)

    Active, not recruiting
    • Diabetes Mellitus, Type I
    • Miami, Florida
      University of Miami, Diabetes Research Institute
    Mar 1, 2022

    Type1diabetes, Hypoglycemia, Hypoglycemia Unawareness Trial in Philadelphia (Phentolamine, Propranolol, Placebo)

    Active, not recruiting
    • Type1diabetes
    • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania - Institute for Diabetes, Obesity and
    Mar 3, 2022

    Inflammation, Immunity, Islet Cell and Intestinal Hormone

    Completed
    • Obesity
    • +9 more
      • Toronto, Ontario, Canada
        The Hospital for Sick Children
      Sep 12, 2022

      Chronic Pancreatitis, Diabetes Trial in Charleston (autologous mesenchymal stromal cell)

      Completed
      • Chronic Pancreatitis
      • Diabetes
      • autologous mesenchymal stromal cell
      • Charleston, South Carolina
        GI Surgery, Medical University of South Carolina
      Mar 23, 2022

      Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Head and Neck Squamous Cell Carcinoma
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Oct 25, 2023

      Renal Cell Carcinoma Trial (Sunitinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 11, 2023

      Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Recruiting
      • Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jun 5, 2023

      Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal

      Not yet recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • Basal Cell Carcinoma of Skin
      • microscopy confocal (Histolog Scanner)
      • Vandœuvre-lès-Nancy, France
        Gilles Dolivet
      Jul 7, 2023

      Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

      Recruiting
      • Squamous Cell Carcinoma of Oral Cavity
      • +3 more
      • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
      • Gliwice, Silesia, Poland
        The Maria Sklodowska-Curie National Research Institute of Oncolo
      Aug 7, 2023

      Delving Into Participation Trends in Renal Cell Carcinoma

      Not yet recruiting
      • Renal Cell Carcinoma
        • San Francisco, California
          Power Life Sciences
        Oct 16, 2023

        Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

        Not yet recruiting
        • Clear Cell Renal Cell Carcinoma
        • 68Ga-NY104 PET/CT
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        May 18, 2023